Michael Bui
Family · Laguna Hills, CANPI 1740919398
Payments from drug & device makers
Across 205 payments — averaging $22.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$768
- AbbVie$371
- Xeris Pharmaceuticals, Inc.$289
- Bayer$237
- Insulet Corporation$228
- Cequr Corporation$218
- plus $2K from 29 others
What the payments were for
- Food & beverage$4,532100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 51 | $768 |
| AbbVie | 15 | $371 |
| Xeris Pharmaceuticals, Inc. | 17 | $289 |
| Bayer | 7 | $237 |
| Insulet Corporation | 10 | $228 |
| Cequr Corporation | 2 | $218 |
| Novo Nordisk | 10 | $212 |
| Antares Pharma, Inc. | 9 | $192 |
| Mannkind Corporation | 11 | $189 |
| Amgen(2 entities) | 6 | $154 |
| Merck | 5 | $137 |
| Radius Health, Inc. | 5 | $126 |
| Accord Healthcare, Inc. | 6 | $125 |
| Embecta Corp. | 4 | $106 |
| Dexcom, Inc. | 5 | $101 |
| Astellas Pharma Global Development | 2 | $94 |
| Johnson & Johnson | 4 | $92 |
| Immunitybio, Inc. | 4 | $91 |
| Recordati_rare_diseases_inc. | 3 | $77 |
| Tandem Diabetes Care, Inc. | 3 | $76 |
| Medtronic | 2 | $75 |
| Teleflex LLC | 2 | $72 |
| Boehringer Ingelheim | 3 | $60 |
| IBSA Pharma Inc. | 3 | $58 |
| Corcept Therapeutics | 2 | $55 |
| Sumitomo Pharma America, Inc. | 2 | $54 |
| Urogen Pharma, Inc. | 1 | $45 |
| Novartis | 2 | $42 |
| Tolmar, Inc. | 2 | $40 |
| Halozyme Inc | 2 | $36 |
| Sanofi-aventis U.S. LLC | 1 | $31 |
| Averitas Pharma Inc. | 1 | $26 |
| Ascensia Diabetes Care US Inc. | 1 | $25 |
| Amryt Pharma Holdings Ltd | 1 | $16 |
| Amphastar Pharmaceuticals, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- CeQur Simplicity$150
- Kerendia$115
How this compares
$4,532 in reported general payments places this provider in the 90th percentile of 10,634 family providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 258 | $399,989 |
| JardianceEmpagliflozin | 256 | $264,618 |
| Synjardy XrEmpagliflozin/Metformin Hcl | 87 | $80,993 |
| TrulicityDulaglutide | 38 | $48,151 |
| TradjentaLinagliptin | 50 | $44,438 |
| Trijardy XrEmpaglifloz/Linaglip/Metformin | 44 | $44,106 |
| MounjaroTirzepatide | 23 | $35,619 |
| Tresiba Flextouch U-100Insulin Degludec | 57 | $30,918 |
| SynjardyEmpagliflozin/Metformin Hcl | 28 | $28,602 |
| FarxigaDapagliflozin Propanediol | 34 | $26,238 |
| JanuviaSitagliptin Phosphate | 21 | $25,763 |
| Gvoke Hypopen 2-PackGlucagon | 33 | $20,019 |
| Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog | 22 | $18,074 |
| Toujeo SolostarInsulin Glargine,hum.Rec.Anlog | 44 | $15,947 |
| Cinacalcet Hcl | 13 | $12,345 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance, Synjardy Xr, Tradjenta, Trijardy Xr, Synjardy | $60 | $462,757465 claims |
| Novo NordiskOzempic | $212 | $399,989258 claims |
| Lilly USA, LLCTrulicity, Mounjaro | $768 | $83,77061 claims |
| MerckJanuvia | $137 | $25,76321 claims |
| Sanofi-aventis U.S. LLCSoliqua 100-33 | $31 | $10,33111 claims |
| AbbVieSynthroid | $371 | $3,34342 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 10,634 family providers in California.
Other family in Laguna Hills
- Lindsey WatkinsLaguna Hills$58K
- Lori RobertsonChino Hills$475K
- Annette ShonLos Angeles$406K
- Nancy GardettoSan Diego$394K
- Lisa HigginsHanford$311K
- Jennifer TougasBakersfield$302K
- Kim SchaferSacramento$288K
- Dawn MeyerSan Diego$270K
- Jennifer KangCerritos$255K
- Jenine StoneEscondido$231K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.